Results 111 to 120 of about 10,634,853 (332)

Interview: Radhika Polisetty

open access: yesEMJ Microbiology & Infectious Diseases, 2023
Radhika Polisetty
doaj   +1 more source

Emerging infectious diseases and insensible bacillus infectious diseases. Emerging infectious diseases. O157 infectious disease.

open access: yesNihon Naika Gakkai Zasshi, 1997
1996年夏に多発した腸管出血性大腸菌O157感染症は医学的,細菌学的のみならず社会的な問題ともなった.本年になっても多くの集団例,散発例が報告され,けっして我々のまわりからO157の危険が去ったわけではない. O157感染症の大きな問題点はその病態が単なる食中毒のような腸管感染症にとどまらず, HUSや脳症のような重篤な合併症を併発し全身性感染症的要素を有すること,また合併症に対する有効な治療法が確立していないことである.
openaire   +2 more sources

CD9‐association with PIP2 areas is regulated by a CD9 salt bridge

open access: yesFEBS Open Bio, EarlyView.
The tetraspanin CD9 has an intracellular salt bridge. If CD9 opens, open‐CD9 moves from PIP2‐rich areas to regions populated by its interaction partner EWI‐2. Hence, the state of the salt bridge regulates the distribution of CD9 and by this CD9‐EWI‐2 complex formation.
Yahya Homsi   +2 more
wiley   +1 more source

Characterization of WAC interactions with R2TP and TTT chaperone complexes linking glucose and glutamine availability to mTORC1 activity

open access: yesFEBS Open Bio, EarlyView.
TTT and R2TP chaperone complexes are required for the assembly and activation of mTORC1. WAC directly interacts with components of TTT, R2TP, and mTORC1, and these interactions are affected by the availability of glucose and glutamine, correlating with changes in mTORC1 activity.
Sofía Cabezudo   +11 more
wiley   +1 more source

Ro 31‐8220 suppresses bladder cancer progression via enhancing autophagy in vitro and in vivo

open access: yesFEBS Open Bio, EarlyView.
The pan‐protein kinase C inhibitor Ro‐31‐8220 demonstrates potent anti‐bladder cancer effects both in vitro and in vivo by suppressing migration/invasion, inducing apoptosis and crucially activating autophagy, where blocking autophagy with chloroquine reduces its cell‐killing efficacy, suggesting its promise as a novel therapeutic candidate requiring ...
Shengjun Fu   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy